In postmortem human AD patients, Dyrk1a activity is increased in several brain regions and is enriched in fractions containing phosphorylated tau, suggesting a possible contribution of this kinase in tau pathogenesis (Ferrer et al., 2005). Here, MAPT is linked to Alzheimer disease.